104 related articles for article (PubMed ID: 8888446)
1. Target antigen for anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Stoffel MP; Csernok E; Gross WL
Scand J Gastroenterol; 1996 Sep; 31(9):943-4. PubMed ID: 8888446
[No Abstract] [Full Text] [Related]
2. Bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibodies (ANCA) and associated diseases: clinical relevance of an emerging ANCA target antigen.
Emmi L; Chatzipetrou A
Ann Ital Med Int; 2005; 20(4):205-8. PubMed ID: 16610250
[No Abstract] [Full Text] [Related]
3. Recognition of bactericidal/permeability-increasing protein by perinuclear anti-neutrophil cytoplasmic antibody-positive sera from ulcerative colitis patients: prevalence and clinical significance.
Vecchi M; Sinico A; Bianchi MB; Radice A; Gionchetti P; Campieri M; de Franchis R
Scand J Gastroenterol; 1998 Dec; 33(12):1284-8. PubMed ID: 9930392
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
[TBL] [Abstract][Full Text] [Related]
5. Use of native and recombinant bactericidal/permeability-increasing proteins (BPI) as antigens for detection of BPI-ANCA.
Schultz H; Csernok E; Johnston TW; Lockwood CM; Gross WL
J Immunol Methods; 1997 Jul; 205(2):127-33. PubMed ID: 9294593
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein.
Schinke S; Fellermann K; Herlyn K; Reichel PH; Fundke R; Stange EF; Gross WL; Schultz H
Inflamm Bowel Dis; 2004 Nov; 10(6):763-70. PubMed ID: 15626895
[TBL] [Abstract][Full Text] [Related]
7. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders.
Stoffel MP; Csernok E; Herzberg C; Johnson T; Carroll SF; Gross WL
Clin Exp Immunol; 1996 Apr; 104(1):54-9. PubMed ID: 8603534
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
[TBL] [Abstract][Full Text] [Related]
9. Perinuclear Antineutrophil Cytoplasmic Antibody with a Large Portion Being Anti-β-Glucuronidase, May Have Played a Causative Role in the Pathogenesis of Inflammatory Bowel Disease.
Qin X
Inflamm Bowel Dis; 2016 Nov; 22(11):E41-E42. PubMed ID: 27618502
[No Abstract] [Full Text] [Related]
10. Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibody.
Matsuyama W; Wakimoto J; Watanabe A; Kubota I; Hirotsu Y; Mizoguchi A; Iwami F; Kawabata M; Osame M
Intern Med; 1999 Oct; 38(10):813-6. PubMed ID: 10526946
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
Kim BG; Kim YS; Kim JS; Jung HC; Song IS
Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy.
Terjung B; Worman HJ; Herzog V; Sauerbruch T; Spengler U
Clin Exp Immunol; 2001 Oct; 126(1):37-46. PubMed ID: 11678897
[TBL] [Abstract][Full Text] [Related]
13. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
Schultz H; Weiss J; Carroll SF; Gross WL
J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
[TBL] [Abstract][Full Text] [Related]
14. From infection to autoimmunity: a new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI).
Schultz H
Autoimmun Rev; 2007 Mar; 6(4):223-7. PubMed ID: 17317612
[TBL] [Abstract][Full Text] [Related]
15. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies in children.
Sedivá A; Kolárová I; Bartůnková J
Eur J Pediatr; 1998 Dec; 157(12):987-91. PubMed ID: 9877037
[TBL] [Abstract][Full Text] [Related]
17. Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?
Roozendaal C; Pogány K; Horst G; Jagt TG; Kleibeuker JH; Nelis GF; Limburg PC; Kallenberg CG
Scand J Gastroenterol; 1999 Nov; 34(11):1123-31. PubMed ID: 10582764
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to bactericidal/permeability-increasing protein and cathepsin G in systemic sclerosis.
Grypiotis P; Cozzi F; Ruffatti A
J Rheumatol; 2004 Jul; 31(7):1468-9. PubMed ID: 15229985
[No Abstract] [Full Text] [Related]
19. Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha1-antitrypsin deficiency.
Mahadeva R; Zhao MH; Stewart S; Cary N; Flower C; Lockwood M; Shneerson J
Chest; 1997 Dec; 112(6):1699-701. PubMed ID: 9404779
[TBL] [Abstract][Full Text] [Related]
20. Systemic vasculitis associated with anti-neutrophil cytoplasmic antibodies against bactericidal/permeability increasing protein.
Fukuhara A; Tanino Y; Sato S; Ishii T; Nikaido T; Kanazawa K; Saito J; Ishida T; Kanno M; Watanabe T; Munakata M
Intern Med; 2013; 52(10):1095-9. PubMed ID: 23676597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
